亚太粪便诊断市场 – 行业趋势及 2030 年预测

Customize Your Report Customize Your Report 立即购买 立即购买 免费样本报告 免费样本报告
Home Medical Devices Asia Pacific Stool Diagnostic Market
请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太粪便诊断市场 – 行业趋势及 2030 年预测

  • Medical Devices
  • Published Report
  • Apr 2023
  • Asia-Pacific
  • 350 页面
  • 桌子數： 362
  • 图号： 43
立即购买 立即购买

Asia Pacific Stool Diagnostic Market

市场规模（十亿美元）

CAGR :  % Diagram

Diagram Forecast Period
 2024 –2030
Diagram Market Size (Base Year)
 USD MILLION
Request
Diagram Market Size (Forecast Year)
 USD 452,156.67
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

亚太粪便诊断市场，按测试类型（粪便潜血测试、粪便生物标志物测试、病原体测试、粪便抗原测试、粪便弹性蛋白酶测试、显微镜测试和其他测试）、产品类型（仪器和试剂）、模式（基于实验室的测试和即时诊断测试）、应用（肠易激综合征、溃疡性结肠炎、克罗恩病、癌症、腹泻、痔疮等）、最终用户（医院、诊断中心、实验室、专科诊所、学术机构和研究中心等）、分销渠道（直接招标、零售销售、在线销售等）划分 - 行业趋势和预测到 2030 年。

亚太粪便诊断市场

亚太粪便诊断市场分析与洞察

人们对粪便诊断的认识不断提高，增加了市场需求。为提供更好的医疗服务而增加的医疗支出也促进了市场增长——主要市场参与者在关键时期关注各种服务的推出和批准。此外，工艺和技术的改进也促进了粪便诊断需求的增加。

亚太粪便诊断市场亚太粪便诊断市场

由于市场参与者的增加以及先进产品和服务的可用性，预计亚太地区粪便诊断市场将在预测年内增长。与此同时，制造商也致力于开发活动，以在市场上推出新颖的服务和高效、准确的粪便诊断。

预计医疗保健支出的增加将为市场带来机遇。然而，高昂的检测成本可能会对市场增长构成挑战。

Data Bridge Market Research分析，到2030年，亚太地区粪便诊断市场预计将达到452,156.67万美元，预测期内的复合年增长率为7.1%。

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021 (可定制为 2015-2020)

定量单位

收入（百万美元），定价（美元）

涵盖的领域

按检测类型（粪便潜血检测、粪便生物标志物检测、病原体检测、粪便抗原检测、粪便弹性蛋白酶检测、显微镜检测及其他检测）、产品类型（仪器和试剂）、模式（实验室检测和即时检测）、应用（肠易激综合征、溃疡性结肠炎、克罗恩病、癌症、腹泻、痔疮及其他）、最终用户（医院、诊断中心、实验室、专科诊所、学术机构和研究中心及其他）、分销渠道（直接招标、零售、在线销售及其他）

覆盖国家

日本、中国、韩国、印度、新加坡、泰国、印度尼西亚、马来西亚、菲律宾、澳大利亚、新西兰、越南、台湾、文莱、尼泊尔、孟加拉国、斯里兰卡、巴基斯坦、香港、马尔代夫、蒙古、柬埔寨、老挝和亚太地区其他地区

涵盖的市场参与者

亚太地区粪便诊断市场的一些主要公司包括雅培、Meridian Bioscience Inc.、BIOMERIEUX、贝克曼库尔特公司 (Danaher 的子公司)、DiaSorin SpA、Runmei、Molbio Diagnostics Pvt. Ltd.、Quidel Corporation、Prenetics Limited、Sekisui Diagnostics (SEKISUI Chemical Co. Ltd. 的一部分)、BioVendor Group、LifeSign LLC、Alfa Scientific Designs, Inc.、Eiken Chemical Co., Ltd.、SD Biosensor, INC.、Cenogenics Corporation、TransGen Biotech Co., Ltd.、AdvaCare Pharma、Kibion​​ GmbH 和北京华根安邦科技有限公司等。

亚太粪便诊断市场定义

粪便诊断是对粪便样本进行的一系列测试，有助于诊断某些消化道疾病。其中一些疾病包括感染（寄生虫、病毒或细菌）、营养吸收不良和癌症。显微镜检查以及化学、免疫学和微生物学测试都是粪便分析的一部分。借助粪便诊断，白细胞、潜血、脂肪、糖（还原物质）、pH、胰腺酶、α-1 抗胰蛋白酶、钙卫蛋白和感染性病因都可以在粪便样本中检测到。

粪便检查有助于确定肠道是否被细菌或其他微生物感染。然而，肠道中的微生物并非全都是有害的；事实上，有些微生物是正常消化所必需的。当有害细菌或寄生虫感染肠道时，会引起血性腹泻，粪便诊断有助于确定这种疾病的来源。

亚太粪便诊断市场动态

本节旨在了解市场驱动因素、优势、机遇、限制和挑战。下面将详细讨论所有这些内容：    

司机

  • 胃肠道疾病患病率上升  

胃肠道疾病的患病率不断上升，推动了粪便诊断的需求。胃肠道疾病可引起许多症状，包括腹泻、便秘、腹痛和恶心。包括感染和炎症性肠病在内的各种疾病都可能导致这些症状。

除了对胃肠道疾病粪便诊断的需求日益增长外，人们对使用粪便测试监测微生物群的兴趣也日益浓厚。微生物群是指生活在肠道中并在消化和整体健康中发挥重要作用的微生物群落。粪便测试可以提供有关微生物群组成和功能的信息，这些信息可用于识别菌群失调（微生物群失衡）并指导干预措施以改善肠道健康。

非侵入性粪便检测在筛查和监测微生物群方面的应用日益广泛，这可能会改善患者的治疗效果并减轻胃肠道疾病的负担。因此，胃肠道疾病的患病率不断上升，推动了粪便诊断的需求，尤其是在亚太地区。

克制

  • 严格的政府监管

亚太地区各种检测试剂的使用量正在迅速增加。随着各种胃肠道疾病和癌症的发病率不断上升，需要及时诊断和治疗。同时，市场上的制造商必须遵循一定的规定才能获得上级部门的批准才能推出产品。需要遵循这些严格的指导方针；这是所有步骤中最困难的任务之一。

各种疾病的发病率不断上升，导致民众对治疗方案的需求激增。然而，这些粪便诊断所涉及的不确定性和风险导致监管环境严格而复杂。由于这种产品审批方法严格且耗时，产品因不符合规定而难以获得批准。因此，严格的产品审批规则和法规限制了亚太地区粪便诊断市场的增长。

亚太粪便诊断市场

机会

粪便诊断样本采集和处理的进展

样本采集和处理技术的进步在提高粪便诊断的准确性和可靠性方面发挥了至关重要的作用。传统的粪便诊断测试需要患者采集和处理粪便样本，这可能很不方便，也很不愉快。然而，样本采集和处理技术的进步使粪便诊断对患者更加友好、高效和准确。

因此，技术进步使得粪便诊断更加便捷和高效，从而可以更早地发现和治疗胃肠道疾病。随着技术的进步，我们可以期待样本采集和处理方面取得更多进步，从而造福粪便诊断领域。因此，样本采集和处理的进步为提高该过程的准确性、可靠性和患者友好度提供了机会。

挑战

缺乏熟练且经过认证的专业人员  

粪便诊断需要技能娴熟且经过认证的专业人员，这是一大挑战。亚太地区胃肠道疾病和结直肠癌病例增加，导致粪便诊断需求增加。然而，诊断中心技能娴熟的专业人员较少，阻碍了市场的增长。

粪便诊断是当今困难时期的一个动态组成部分，为患者提供诊断、预防、治疗和管理疾病和癌症的基本信息。对训练有素的员工的需求是亚太粪便诊断市场面临的一大问题。由于缺乏熟练和认证的专业人员，最终用户无法安装先进的粪便诊断产品；这可能会对亚太粪便诊断市场的增长构成挑战。

新冠肺炎疫情对亚太地区粪便诊断市场的影响分析

自 2020 年初以来，新冠疫情给诊断行业造成了巨大冲击，患者数量急剧下降。疫情在人们心中引发了一种可怕的恐惧感，最终影响了医院/诊所和实验室就诊。定期检查变得繁琐、紧张且耗时。虽然整个诊断行业似乎遭遇了衰退，但家庭诊断领域却是新形势下的一线希望。

最新动态

  • 2022 年 6 月，Prenetics Limited (Nasdaq: PRE) 宣布推出一种新型、非侵入性粪便 DNA 家用筛查测试，名为 ColoClear by Circle (ColoClear)，用于检测结直肠癌的早期检测迹象。该产品的推出有助于该公司扩大其产品组合
  • 2022 年 6 月，Meridian Bioscience, Inc. 宣布推出两款新的样本专用预混液，Lyo-Ready Direct DNA qPCR 粪便混合物和 Lyo-Ready Direct RNA/DNA qPCR 粪便混合物。这些创新的预混液可改善粗粪便样本的 DNA 和 RNA 分子检测，同时允许诊断检测在室温下稳定。该产品的推出帮助该公司扩大了产品组合

亚太粪便诊断市场范围

亚太粪便诊断市场分为六个显著的细分市场，例如检测类型、产品类型、模式、应用、最终用户和分销渠道。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。  

亚太粪便诊断市场（按测试类型划分）

  • 粪便潜血检测
  • 粪便生物标志物检测
  • 病原体检测
  • 粪便抗原检测
  • 粪便弹性蛋白酶检测
  • 显微镜检查
  • 其他测试

根据测试类型，亚太粪便诊断市场分为粪便潜血测试、粪便生物标志物测试、病原体测试、粪便抗原测试、粪便弹性蛋白酶测试、显微镜测试和其他测试。

亚太粪便诊断市场（按产品类型划分）

  • 仪器
  • 试剂

根据产品类型，亚太粪便诊断市场分为仪器和试剂。

亚太地区凳子诊断市场（按模式划分）

  • 实验室测试
  • 即时检验

根据模式，亚太地区粪便诊断市场分为实验室检测和即时诊断。

亚太地区粪便诊断市场（按应用划分）

  • 肠易激综合症
  • 溃疡性结肠炎
  • 克罗恩病
  • 癌症
  • 腹泻
  • 痔疮
  • 其他的

根据应用，亚太粪便诊断市场分为肠易激综合征、溃疡性结肠炎、克罗恩病、癌症、腹泻、痔疮等。

亚太地区凳子诊断市场（按最终用户划分）

  • 医院
  • 诊断中心
  • 实验室
  • 专科诊所
  • 学术机构和研究中心
  • 其他的

根据最终用户，亚太粪便诊断市场分为医院、诊断中心、实验室、专科诊所、学术机构和研究中心等。

亚太地区凳子诊断市场，按分销渠道划分

  • 直接招标
  • 零售销售
  • 网上销售
  • 其他的

根据分销渠道，亚太粪便诊断市场分为直接招标、零售、在线销售和其他。

亚太粪便诊断市场

亚太粪便诊断市场区域分析/见解

亚太粪便诊断市场分为六个显著部分：测试类型、产品类型、模式、应用、最终用户和分销渠道。

本市场报告涉及的国家包括日本、中国、韩国、印度、新加坡、泰国、印度尼西亚、马来西亚、菲律宾、澳大利亚、新西兰、越南、台湾、文莱、尼泊尔、孟加拉国、斯里兰卡、巴基斯坦、香港、马尔代夫、蒙古、柬埔寨、老挝和亚太其他地区。

由于客户对先进技术工艺的倾向日益增加，中国有望在亚太地区占据主导地位。

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和国内法规变化。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了亚太品牌的存在和可用性以及由于来自本地和国内品牌的激烈或稀缺竞争而面临的挑战以及销售渠道的影响。

竞争格局和亚太粪便诊断市场份额分析

亚太粪便诊断市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品批准、产品宽度和广度、应用主导地位以及产品类型生命线曲线。以上数据点仅与公司对亚太粪便诊断市场的关注有关。

亚太地区粪便诊断市场的一些主要公司包括雅培、Meridian Bioscience Inc.、BIOMERIEUX、贝克曼库尔特公司 (Danaher 的子公司)、DiaSorin SpA、Runmei、Molbio Diagnostics Pvt. Ltd.、Quidel Corporation、Prenetics Limited、Sekisui Diagnostics (SEKISUI Chemical Co. Ltd. 的一部分)、BioVendor Group、LifeSign LLC、Alfa Scientific Designs, Inc.、Eiken Chemical Co., Ltd.、SD Biosensor, INC.、Cenogenics Corporation、TransGen Biotech Co., Ltd.、AdvaCare Pharma、Kibion​​ GmbH 和北京华根安邦科技有限公司等。

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

目录

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TEST TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTER’S FIVE FORCES

5 INDUSTRY INSIGHTS

6 REGULATIONS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASING PREVALENCE OF GASTROINTESTINAL DISEASE

7.1.2 INCREASING PREVALENCE OF ESOPHAGEAL, COLORECTAL, AND GASTRIC CANCERS

7.1.3 RISING DEMAND FOR EARLY DISEASE DIAGNOSIS

7.2 RESTRAINTS

7.2.1 STRICT GOVERNMENT REGULATIONS

7.2.2 HIGH COST ASSOCIATED WITH STOOL DIAGNOSIS

7.3 OPPORTUNITIES

7.3.1 ADVANCEMENTS IN SAMPLE COLLECTION AND HANDLING FOR STOOL DIAGNOSTICS

7.3.2 RISING DEMAND FOR NON-INVASIVE OR MINIMAL INVASIVE STOOL DIAGNOSTICS

7.4 CHALLENGES

7.4.1 LACK OF SKILLED & CERTIFIED PROFESSIONALS

7.4.2 LACK OF STANDARDIZATION IN STOOL DIAGNOSTIC PROCEDURE

8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE

8.1 OVERVIEW

8.2 PATHOGEN TEST

8.2.1 H. PYLORI TEST

8.2.1.1 H. PYLORI ANTIGEN TEST

8.2.1.2 UREA BREATH TEST

8.2.2 C. DEFFCILE TEST

8.2.3 OVA & PARASITE TEST

8.2.4 ROTAVIRUS TEST

8.2.5 ADENOVIRUS TEST

8.2.6 SALMONELLA CULTURE TEST

8.2.7 CAMPYLOBACTER TEST

8.2.8 EHEC TEST

8.2.9 OTHERS

8.3 FECAL OCCULT BLOOD TEST

8.3.1 LATERAL FLOW IMMUNO-FOB TEST

8.3.2 IMMUNO-FOB AGGLUTINATION TEST

8.3.3 GUAIC FOB STOOL TEST

8.3.4 OTHERS

8.4 FECAL BIOMARKERS TEST

8.4.1 INFLAMMATORY BIOMARKERS TEST

8.4.1.1 FECAL CALPROTECTIN

8.4.1.2 FECAL LACTOFERRIN

8.4.1.3 OTHERS

8.4.2 CANCER BIOMARKERS TEST

8.4.2.1 COLOGUARD

8.4.2.2 M2 PK STOOL TEST

8.4.2.3 OTHERS

8.4.3 OTHERS

8.5 MICROSCOPY TEST

8.6 STOOL ANTIGEN TEST

8.7 FECAL ELASTASE TEST

8.8 OTHER TESTS

9 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 REAGENTS

9.2.1 FECAL FLOAT SOLUTIONS

9.2.2 BUFFER SOLUTIONS

9.2.3 ABSOLUTE METHANOL

9.2.4 ACID ALCOHOL

9.2.5 OTHERS

9.3 INSTRUMENTS

9.3.1 FECALYZERS

9.3.2 DIGITAL SCALES

9.3.3 MICROSCOPES

9.3.4 MICROSCOPE SLIDES

9.3.5 MICROSCOPE COVER SLIPS

9.3.6 OTHERS

10 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY MODE

10.1 OVERVIEW

10.2 LABORATORY BASED TESTING

10.3 POINT OF CARE TESTING

11 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 DIARRHEA

11.3 IRRITABLE BOWEL SYNDROME

11.4 HEMORRHOIDS

11.5 ULCERATIVE COLITIS

11.6 CANCER

11.6.1 COLORECTAL

11.6.2 COLON

11.6.3 OTHER

11.7 CROHN’S DISEASE

11.8 OTHERS

 

12 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY END USER

12.1 OVERVIEW

12.2 HOSPITALS

12.3 DIAGNOSTIC CENTERS

12.4 LABORATORIES

12.5 SPECIALTY CLINICS

12.6 ACADEMIC INSTITUTES AND RESEARCH CENTERS

12.7 OTHERS

13 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDERS

13.3 RETAIL SALES

13.4 ONLINE SALES

13.5 OTHERS

14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET BY REGION

14.1 ASIA-PACIFIC

14.1.1 CHINA

14.1.2 JAPAN

14.1.3 INDIA

14.1.4 SOUTH KOREA

14.1.5 AUSTRALIA

14.1.6 MALAYSIA

14.1.7 INDONESIA

14.1.8 PHILIPPINES

14.1.9 THAILAND

14.1.10 NEW ZEALAND

14.1.11 TAIWAN

14.1.12 VIETNAM

14.1.13 HONG KONG

14.1.14 SINGAPORE

14.1.15 PAKISTAN

14.1.16 BANGLADESH

14.1.17 SRI LANKA

14.1.18 CAMBODIA

14.1.19 NEPAL

14.1.20 MONGOLIA

14.1.21 LAOS

14.1.22 MALDIVES

14.1.23 BRUNEI

14.1.24 REST OF ASIA-PACIFIC

15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 EIKEN CHEMICAL CO., LTD.

17.1.1 COMPANY SNAPSHOT

17.1.2 REVENUE ANALYSIS

17.1.3 PRODUCT PORTFOLIO

17.1.4 RECENT DEVELOPMENT

17.2 QUIDEL CORPORATION

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 PRODUCT PORTFOLIO

17.2.4 RECENT DEVELOPMENTS

17.3 BIOMERIEUX

17.3.1 COMPANY SNAPSHOT

17.3.2 REVENUE ANALYSIS

17.3.3 PRODUCT PORTFOLIO

17.3.4 RECENT DEVELOPMENTS

17.4 SD BIOSENSOR, INC.

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 PRODUCT PORTFOLIO

17.4.4 RECENT DEVELOPMENTS

17.5 SEKISUI DIAGNOSTICS (A PART OF SEKISUI CHEMICAL CO. LTD.)

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 PRODUCT PORTFOLIO

17.5.4 RECENT DEVELOPMENTS

17.6 ABBOTT

17.6.1 COMPANY SNAPSHOT

17.6.2 REVENUE ANALYSIS

17.6.3 PRODUCT PORTFOLIO

17.6.4 RECENT DEVELOPMENT

 

17.7 ADVACARE PHARMA

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENTS

17.8 ALFA SCIENTIFIC DESIGNS, INC.

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENTS

17.9 BECKMAN COULTER, INC. (SUBSIDIARY OF DANAHER)

17.9.1 COMPANY SNAPSHOT

17.9.2 REVENUE ANALYSIS

17.9.3 PRODUCT PORTFOLIO

17.9.4 RECENT DEVELOPMENTS

17.1 BEIJING HUAGEN ANBANG TECHNOLOGY CO., LTD.

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENT

17.11 BIOVENDOR GROUP

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENTS

17.12 CENOGENICS CORPORATION

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENTS

17.13 DIASORIN S.P.A.

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUE ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 KIBION GMBH (A SUBSIDIARY OF OREXO AB)

17.14.1 COMPANY SNAPSHOT

17.14.2 REVENUE ANALYSIS

17.14.3 PRODUCT PORTFOLIO

17.14.4 RECENT DEVELOPMENTS

17.15 LIFESIGN LLC

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENTS

 

17.16 MERIDIAN BIOSCIENCE INC.

17.16.1 COMPANY SNAPSHOT

17.16.2 REVENUE ANALYSIS

17.16.3 PRODUCT PORTFOLIO

17.16.4 RECENT DEVELOPMENT

17.17 MOLBIO DIAGNOSTICS PVT. LTD.

17.17.1 COMPANY SNAPSHOT

17.17.2 PRODUCT PORTFOLIO

17.17.3 RECENT DEVELOPMENT

17.18 PRENETICS LIMITED

17.18.1 COMPANY SNAPSHOT

17.18.2 REVENUE ANALYSIS

17.18.3 PRODUCT PORTFOLIO

17.18.4 RECENT DEVELOPMENT

17.19 RUNMEI

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENTS

17.2 TRANSGEN BIOTECH CO., LTD.

17.20.1 COMPANY SNAPSHOT

17.20.2 PRODUCT PORTFOLIO

17.20.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

表格列表

TABLE 1 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 2 ASIA-PACIFIC PATHOGEN TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 3 ASIA-PACIFIC H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 4 ASIA-PACIFIC FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 5 ASIA-PACIFIC FECAL BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 6 ASIA-PACIFIC INFLAMMATORY BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 7 ASIA-PACIFIC CANCER BIOMARKERS TEST IN STOOL DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 9 ASIA-PACIFIC REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 10 ASIA-PACIFIC INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 11 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 12 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 13 ASIA-PACIFIC CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 16 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND)

TABLE 17 CHINA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 18 CHINA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 19 CHINA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 20 CHINA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 21 CHINA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 22 CHINA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 23 CHINA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 24 CHINA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 25 CHINA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 26 CHINA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 27 CHINA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 28 CHINA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 29 CHINA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 30 CHINA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 31 CHINA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 32 JAPAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 33 JAPAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 34 JAPAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 35 JAPAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 36 JAPAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 37 JAPAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 38 JAPAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 39 JAPAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 40 JAPAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 41 JAPAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 42 JAPAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 43 JAPAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 44 JAPAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 45 JAPAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 46 JAPAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 47 INDIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 48 INDIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 49 INDIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 50 INDIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 51 INDIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 52 INDIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 53 INDIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 54 INDIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 55 INDIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 56 INDIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 57 INDIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 58 INDIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 59 INDIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 60 INDIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 61 INDIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 62 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 63 SOUTH KOREA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 64 SOUTH KOREA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 65 SOUTH KOREA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 66 SOUTH KOREA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 67 SOUTH KOREA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 68 SOUTH KOREA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 69 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 70 SOUTH KOREA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 71 SOUTH KOREA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 72 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 73 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 74 SOUTH KOREA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 75 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 76 SOUTH KOREA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 77 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 78 AUSTRALIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 79 AUSTRALIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 80 AUSTRALIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 81 AUSTRALIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 82 AUSTRALIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 83 AUSTRALIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 84 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 85 AUSTRALIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 86 AUSTRALIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 87 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 88 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 89 AUSTRALIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 90 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 91 AUSTRALIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 92 MALAYSIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 93 MALAYSIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 94 MALAYSIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 95 MALAYSIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 96 MALAYSIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 97 MALAYSIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 98 MALAYSIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 99 MALAYSIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 100 MALAYSIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 101 MALAYSIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 102 MALAYSIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 103 MALAYSIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 104 MALAYSIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 105 MALAYSIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 106 MALAYSIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 107 INDONESIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 108 INDONESIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 109 INDONESIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 110 INDONESIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 111 INDONESIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 112 INDONESIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 113 INDONESIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 114 INDONESIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 115 INDONESIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 116 INDONESIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 117 INDONESIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 118 INDONESIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 119 INDONESIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 120 INDONESIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 121 INDONESIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 122 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 123 PHILIPPINES PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 124 PHILIPPINES H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 125 PHILIPPINES FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 126 PHILIPPINES FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 127 PHILIPPINES INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 128 PHILIPPINES CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 129 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 130 PHILIPPINES REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 131 PHILIPPINES INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 132 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 133 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 134 PHILIPPINES CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 135 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 136 PHILIPPINES STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 137 THAILAND STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 138 THAILAND PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 139 THAILAND H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 140 THAILAND FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 141 THAILAND FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 142 THAILAND INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 143 THAILAND CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 144 THAILAND STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 145 THAILAND REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 146 THAILAND INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 147 THAILAND STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 148 THAILAND STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 149 THAILAND CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 150 THAILAND STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 151 THAILAND STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 152 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 153 NEW ZEALAND PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 154 NEW ZEALAND H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 155 NEW ZEALAND FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 156 NEW ZEALAND FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 157 NEW ZEALAND INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 158 NEW ZEALAND CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 159 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 160 NEW ZEALAND REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 161 NEW ZEALAND INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 162 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 163 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 164 NEW ZEALAND CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 165 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 166 NEW ZEALAND STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 167 TAIWAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 168 TAIWAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 169 TAIWAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 170 TAIWAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 171 TAIWAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 172 TAIWAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 173 TAIWAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 174 TAIWAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 175 TAIWAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 176 TAIWAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 177 TAIWAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 178 TAIWAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 179 TAIWAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 180 TAIWAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 181 TAIWAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 182 VIETNAM STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 183 VIETNAM PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 184 VIETNAM H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 185 VIETNAM FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 186 VIETNAM FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 187 VIETNAM INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 188 VIETNAM CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 189 VIETNAM STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 190 VIETNAM REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 191 VIETNAM INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 192 VIETNAM STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 193 VIETNAM STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 194 VIETNAM CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 195 VIETNAM STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 196 VIETNAM STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 197 HONG KONG STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 198 HONG KONG PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 199 HONG KONG H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 200 HONG KONG FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 201 HONG KONG FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 202 HONG KONG INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 203 HONG KONG CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 204 HONG KONG STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 205 HONG KONG REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 206 HONG KONG INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 207 HONG KONG STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 208 HONG KONG STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 209 HONG KONG CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 210 HONG KONG STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 211 HONG KONG STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 212 SINGAPORE STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 213 SINGAPORE PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 214 SINGAPORE H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 215 SINGAPORE FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 216 SINGAPORE FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 217 SINGAPORE INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 218 SINGAPORE CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 219 SINGAPORE STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 220 SINGAPORE REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 221 SINGAPORE INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 222 SINGAPORE STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 223 SINGAPORE STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 224 SINGAPORE CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 225 SINGAPORE STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 226 SINGAPORE STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 227 PAKISTAN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 228 PAKISTAN PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 229 PAKISTAN H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 230 PAKISTAN FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 231 PAKISTAN FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 232 PAKISTAN INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 233 PAKISTAN CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 234 PAKISTAN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 235 PAKISTAN REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 236 PAKISTAN INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 237 PAKISTAN STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 238 PAKISTAN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 239 PAKISTAN CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 240 PAKISTAN STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 241 PAKISTAN STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 242 BANGLADESH STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 243 BANGLADESH PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 244 BANGLADESH H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 245 BANGLADESH FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 246 BANGLADESH FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 247 BANGLADESH INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 248 BANGLADESH CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 249 BANGLADESH STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 250 BANGLADESH REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 251 BANGLADESH INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 252 BANGLADESH STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 253 BANGLADESH STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 254 BANGLADESH CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 255 BANGLADESH STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 256 BANGLADESH STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 257 SRI LANKA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 258 SRI LANKA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 259 SRI LANKA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 260 SRI LANKA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 261 SRI LANKA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 262 SRI LANKA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 263 SRI LANKA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 264 SRI LANKA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 265 SRI LANKA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 266 SRI LANKA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 267 SRI LANKA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 268 SRI LANKA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 269 SRI LANKA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 270 SRI LANKA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 271 SRI LANKA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 272 CAMBODIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 273 CAMBODIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 274 CAMBODIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 275 CAMBODIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 276 CAMBODIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 277 CAMBODIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 278 CAMBODIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 279 CAMBODIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 280 CAMBODIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 281 CAMBODIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 282 CAMBODIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 283 CAMBODIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 284 CAMBODIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 285 CAMBODIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 286 CAMBODIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 287 NEPAL STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 288 NEPAL PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 289 NEPAL H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 290 NEPAL FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 291 NEPAL FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 292 NEPAL INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 293 NEPAL CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 294 NEPAL STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 295 NEPAL REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 296 NEPAL INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 297 NEPAL STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 298 NEPAL STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 299 NEPAL CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 300 NEPAL STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 301 NEPAL STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 302 MONGOLIA STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 303 MONGOLIA PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 304 MONGOLIA H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 305 MONGOLIA FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 306 MONGOLIA FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 307 MONGOLIA INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 308 MONGOLIA CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 309 MONGOLIA STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 310 MONGOLIA REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 311 MONGOLIA INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 312 MONGOLIA STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 313 MONGOLIA STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 314 MONGOLIA CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 315 MONGOLIA STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 316 MONGOLIA STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 317 LAOS STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 318 LAOS PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 319 LAOS H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 320 LAOS FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 321 LAOS FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 322 LAOS INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 323 LAOS CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 324 LAOS STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 325 LAOS REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 326 LAOS INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 327 LAOS STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 328 LAOS STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 329 LAOS CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 330 LAOS STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 331 LAOS STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 332 MALDIVES STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 333 MALDIVES PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 334 MALDIVES H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 335 MALDIVES FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 336 MALDIVES FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 337 MALDIVES INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 338 MALDIVES CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 339 MALDIVES STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 340 MALDIVES REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 341 MALDIVES INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 342 MALDIVES STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 343 MALDIVES STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 344 MALDIVES CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 345 MALDIVES STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 346 MALDIVES STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 347 BRUNEI STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 348 BRUNEI PATHOGEN TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 349 BRUNEI H. PYLORI TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 350 BRUNEI FECAL OCCULT BLOOD TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 351 BRUNEI FECAL BIOMARKERS TEST IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 352 BRUNEI INFLAMMATORY BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 353 BRUNEI CANCER BIOMARKERS TESTS IN STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

TABLE 354 BRUNEI STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 355 BRUNEI REAGENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 356 BRUNEI INSTRUMENTS IN STOOL DIAGNOSTIC MARKET, BY PRODUCT TYPE, 2021-2030 (USD THOUSAND)

TABLE 357 BRUNEI STOOL DIAGNOSTIC MARKET, BY MODE, 2021-2030 (USD THOUSAND)

TABLE 358 BRUNEI STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 359 BRUNEI CANCER IN STOOL DIAGNOSTIC MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND)

TABLE 360 BRUNEI STOOL DIAGNOSTIC MARKET, BY END USER, 2021-2030 (USD THOUSAND)

TABLE 361 BRUNEI STOOL DIAGNOSTIC MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND)

TABLE 362 REST OF ASIA-PACIFIC STOOL DIAGNOSTIC MARKET, BY TEST TYPE, 2021-2030 (USD THOUSAND)

图片列表

FIGURE 1 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 2 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: DATA TRIANGULATION

FIGURE 3 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: DROC ANALYSIS

FIGURE 4 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: ASIA-PACIFIC VS COUNTRY MARKET ANALYSIS

FIGURE 5 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: DBMR MARKET POSITION GRID

FIGURE 8 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 9 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: SEGMENTATION

FIGURE 11 INCREASING PREVALENCE OF GASTROINTESTINAL DIASEASE IS EXPECTED TO DRIVE THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET IN THE FORECAST PERIOD

FIGURE 12 PATHOGEN TEST SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET IN 2023 & 2030

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC STOOL DIAGNOSTIC MARKET

FIGURE 14 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, 2022

FIGURE 15 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, 2023-2030 (USD THOUSAND)

FIGURE 16 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, CAGR (2023-2030)

FIGURE 17 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 18 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2022

FIGURE 19 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, 2023-2030 (USD THOUSAND)

FIGURE 20 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, CAGR (2023-2030)

FIGURE 21 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 22 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, 2022

FIGURE 23 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, 2023-2030 (USD THOUSAND)

FIGURE 24 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, CAGR (2023-2030)

FIGURE 25 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY MODE, LIFELINE CURVE

FIGURE 26 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, 2022

FIGURE 27 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND)

FIGURE 28 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, CAGR (2023-2030)

FIGURE 29 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 30 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, 2022

FIGURE 31 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, 2023-2030 (USD THOUSAND)

FIGURE 32 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, CAGR (2023-2030)

FIGURE 33 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY END USER, LIFELINE CURVE

FIGURE 34 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2022

FIGURE 35 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND)

FIGURE 36 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)

FIGURE 37 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 38 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: SNAPSHOT (2022)

FIGURE 39 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY COUNTRY (2022)

FIGURE 40 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY COUNTRY (2023 & 2030)

FIGURE 41 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: BY COUNTRY (2022 & 2030)

FIGURE 42 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: TEST TYPE (2023-2030)

FIGURE 43 ASIA-PACIFIC STOOL DIAGNOSTIC MARKET: COMPANY SHARE 2022 (%)

查看详细信息 Right Arrow

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Asia-Pacific Stool Diagnostic Market is projected to grow at a CAGR of 7.1% during the forecast period by 2030.
The future market value of the Asia-Pacific Stool Diagnostic Market is expected to reach USD 452,156.67 thousand by 2030.
The major players in the Asia-Pacific Stool Diagnostic Market are Abbott, Meridian Bioscience Inc., BIOMERIEUX, Beckman Coulter, Inc. (Subsidiary of Danaher), DiaSorin S.p.A., Runmei, Molbio Diagnostics Pvt. Ltd., Quidel Corporation, Prenetics Limited, etc.
The countries covered in the Asia-Pacific Stool Diagnostic Market are Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, New Zealand, Vietnam, Taiwan, Brunei, Nepal, Bangladesh, Sri Lanka, Pakistan, Hong Kong, etc.

浏览相关页面

Banner